It has been almost six months since the earliest new case of pneumonia was discovered in Wuhan, China. The epidemic has spread rapidly in breadth and depth. In countries with the largest number of cases, this disease is putting increasing pressure on medical institutions. This article aims to provide the latest insights into the impact of new coronary pneumonia (COVID-19) on the X-ray market.
The absolute necessity of the mobile DR system means that buyers have more flexibility in specifications, and the purchase decision is based entirely on the supply of mobile DR manufacturers. Given the popularity of COVID-19, there has been no change in the pricing dynamics of mobile DR systems.
In response to a similar pandemic in the future, hospitals can focus on purchasing mobile DR systems with antibacterial coatings and easy disinfection, which can enhance the protection of patients and medical staff of software and hardware, faster image processing, workflow optimization and artificial intelligence assistance Clinical decision-making software. Artificial intelligence technology companies are expected to be more proactive in developing customized solutions to deal with such epidemics.
COVID-19 has stimulated the industry to divert funds to X-ray diagnostic systems to help develop much-needed imaging diagnostic facilities, resulting in the growth of the radiographic imaging market in the first and second quarters of 2020 higher than the forecast before COVID-19 . Mobile digital radiography (DR) systems are widely used for initial screening of COVID-19’s more severe and progressive pneumonia.